ANGLE Plc (AGL):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】ANGLE Plc (AGL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C9445)・商品コード:DATA904C9445
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:28
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of disease. Its product Parsortix cell separation system, which captures very rare circulating tumor cells in cancer patient blood. ANGLE’s Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The company’s cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. It provides liquid biopsy (blood test) that enables the detection and investigation of mutations in the patient’s cancer for personalized cancer care. The company’s harvested CTCs have a range of applications such as diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring. It has operations in the US and the UK. ANGLE is headquartered in Guildford, the UK.

ANGLE Plc (AGL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ANGLE Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ANGLE Plc, Medical Devices Deals, 2012 to YTD 2018 9
ANGLE Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ANGLE Plc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
ANGLE Acquires Assets from Axela 11
Private Equity 12
ANGLE Raises USD2.5 Million in Private Placement of Shares 12
Partnerships 13
Angle Enters into Co-Development Agreement with Royal Philips 13
Angle Enters into Agreement with MD Anderson Cancer Center 14
Equity Offering 15
Angle Raises USD16.8 Million in Private Placement of Shares 15
ANGLE Raises USD3.7 Million in Private Placement of Shares 17
ANGLE Raises USD13.7 Million in Private Placement of Shares 18
ANGLE Plc – Key Competitors 19
ANGLE Plc – Key Employees 20
ANGLE Plc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Jul 25, 2018: ANGLE: Preliminary Results for the year ended 30 April 2018 22
Corporate Communications 26
Nov 01, 2018: Appointment of Dr Jan Groen as non-executive director 26
May 14, 2018: Angle Appoints Leading NHS Prostate Cancer Surgeon As Scientific Advisor 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
ANGLE Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ANGLE Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ANGLE Plc, Deals By Therapy Area, 2012 to YTD 2018 8
ANGLE Plc, Medical Devices Deals, 2012 to YTD 2018 9
ANGLE Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ANGLE Acquires Assets from Axela 11
ANGLE Raises USD2.5 Million in Private Placement of Shares 12
Angle Enters into Co-Development Agreement with Royal Philips 13
Angle Enters into Agreement with MD Anderson Cancer Center 14
Angle Raises USD16.8 Million in Private Placement of Shares 15
ANGLE Raises USD3.7 Million in Private Placement of Shares 17
ANGLE Raises USD13.7 Million in Private Placement of Shares 18
ANGLE Plc, Key Competitors 19
ANGLE Plc, Key Employees 20
ANGLE Plc, Other Locations 21

List of Figures
ANGLE Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ANGLE Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ANGLE Plc, Medical Devices Deals, 2012 to YTD 2018 9

★調査レポート[ANGLE Plc (AGL):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C9445)販売に関する免責事項を必ずご確認ください。
★調査レポート[ANGLE Plc (AGL):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆